Economic evaluations based on decision models: A response to Muston et al.

Journal of Dermatological Treatment

Volumn 22, Issue 5, 2011, Pages 298-301

  Wilson, Ed ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; APPLICATION SITE REACTION; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DRUG EFFICACY; ECONOMIC EVALUATION; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RECURRENT DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; HUMANS; KERATOSIS, ACTINIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 80053075758     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546631003797080     Document Type: Letter

References (18)

1. Muston D, Downs A, Rives V. An economic evaluation of topical treatments for actinic keratosis. J Dermatolog Treat. 2009;20(5):266-275.
2. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol. 2005;85(5):424-428. (Pubitemid 41345617)
3. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: A prospective, randomized study. J Dermatolog Treat. 2003;14(2):99-106. (Pubitemid 36648700)
4. Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate- photodynamic therapy and cryo-therapy in subjects with actinic keratoses: A multicentre, randomized controlled study. Br J Dermatol. 2006;155(5): 1029-1036. (Pubitemid 44564515)
5. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryo-therapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol. 2002;47(2):258-262.
6. Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, et al. Indirect comparisons of competing interventions. Health Technol Assess. 2005;9(26):1-134
7. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE; 2008.
8. Alomar A, Bichel J, McRae S. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imi-quimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol. 2007;157(1):133-141. (Pubitemid 46934262)
9. Jorizzo J, Dinehart S, Matheson R, Moore JK, Ling M, Fox TL, et al. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007;57(2):265-268. (Pubitemid 47048863)
10. Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: Phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol. 2006;155(6): 1262-1269. (Pubitemid 44730005)
11. Metvix 160 mg/g cream summary of product characteristics. Electronic Medicines Compendium; 2007 [cited]. Accessed 2010 April 18. Available from: http://www.medicines.org.uk/EMC/medicine/11913/SPC/Metvix+ 160+mg +g +cream/
12. Aldara 5% cream summary of product characteristics. Electronic Medicines Compendium; 2007 [cited]. Accessed 2010 April 18. Available from: http://www.medicines.org.uk/EMC/medicine/8/SPC/Aldara+5%25+Cream/
13. Littenberg B, Partilo S, Licata A, Kattan MW. Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making. 2003;23(6):480-488. (Pubitemid 37448913)
14. Chen SC, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, et al. A catalog of dermatology utilities: A measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9(2):160-168. (Pubitemid 38457275)
15. Mooney G. QALYs: Are they enough? A health economist's perspective. J Med Ethics. 1989;15(3):148-152. (Pubitemid 20089058)
16. Nord E, Enge AU, Gundersen V. QALYs: Is the value of treatment proportional to the size of the health gain? Health Econ. Epub 2009 May 20.
17. Brouwer W, van Exel J, Baker R, Donaldson C. The new myth: The social value of the QALY. Pharmacoeconomics. 2008;26(1):1-4.
18. Briggs AH, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.